The FDA has cleared Tandem Diabetes Care to market its t:connect diabetes management software. The technology, set to be released next month, provides diabetes patients and their doctors with electronic access to information from the company's t:slim insulin delivery systems and blood glucose monitors.
Diabetes management software from Tandem gets FDA OK
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|